Cancer Clinical Trial
Official title:
Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis: an International, Multicentre, Observational Cohort Study (CovidSurg-Cancer)
CovidSurg-Cancer is an international, multicentre, observational cohort study designed to
evaluate the 30-day COVID-19 infection rates in elective cancer surgery during the COVID-19
pandemic.
Centres can elect to include one or more cancer types in the study, in any combination,
depending on local expertise and capacity. During the pilot study, investigators should enrol
patients with confirmed diagnoses of:
- Colorectal cancer
- Oesophagogastric cancer
As a rapid response study to the COVID-19 pandemic, included cancer types will evolve
throughout the course of the CovidSurg-Cancer study period, for example, to include breast,
liver, pancreatic, gynaecological, urological cancers, or sarcomas.
The rapid emergence of the COVID-19 virus has led to a global impact on elective surgical
care.
We have very little evidence to guide us. The magnitude and effects of these changes are
uncertain. The safety of operating on patients electively with the risks of COVID-19
postoperative pneumonia is unknown.
High-quality data will allow policy planning at regional and hospital level for both this
outbreak and future pandemics. CovidSurg-Cancer will run in parallel to CovidSurg (which is
capturing outcomes of patients undergoing surgery for all indications with concurrent
COVID-19).
The primary aim is to evaluate the 30-day COVID-19 infection rates in elective cancer surgery
during the COVID-19 pandemic.
Secondary aims include; comparison of the 30-day postoperative mortality rate in cancer
surgery patients that develop COVID-19 infection versus those who do not; an exploration of
the scale of resource constraints related to the COVID-19 pandemic, and their impact on
outcomes of elective cancer surgery; to explore variation in the selection of patients for
continuing elective cancer surgery during the COVID-19 pandemic; to evaluate the impact of
the COVID-19 pandemic on treatment pathways for cancers with a decision for surgical
resection with curative intent.
This investigator-led, non-commercial, non-interventional study is extremely low to zero
risk. This study does not collect any patient identifiable information and data will not be
analysed at hospital-level.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|